Inventor
WURTZ NICHOLAS R
US15 patents
Patents
15 patentsUS10676431B2Jun 9, 2020
Phenylpyrrolidinone formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO6 citations80
US10717708B2Jul 21, 2020
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO3 citations71
US11186544B2Nov 30, 2021
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO2 citations69
US11117861B2Sep 14, 2021
Phenylpyrrolidinone formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO2 citations69
US11530183B2Dec 20, 2022
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations60
US11708327B2Jul 25, 2023
Phenylpyrrolidinone formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO1 citations59
US11008301B2May 18, 2021
Piperidinone formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO1 citations56
US12577206B2Mar 17, 2026
Pyrazolone formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations50
US11180490B2Nov 23, 2021
Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations50
US12281108B2Apr 22, 2025
Pyrrolidinone derivatives as formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations49
US11124494B2Sep 21, 2021
Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations49
US11008317B2May 18, 2021
Triazolopyridine inhibitors of myeloperoxidase and/or EPX
BRISTOL MYERS SQUIBB CO0 citations49
US9920075B2Mar 20, 2018
Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO1 citations48
US10981879B2Apr 20, 2021
Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO0 citations47
US12565483B2Mar 3, 2026
Oxopyrrolidine urea FPR2 agonists
BRISTOL MYERS SQUIBB CO0 citations46